147 related articles for article (PubMed ID: 38669361)
1. Experience of multi-disciplinary treatment of multiple cerebellar diffuse large B-cell lymphoma: A case report.
Guo Y; Li J; Li M; Li Z; Cui Y; Li Y; Zhao R; Han Q; Yang H; Ma C
Medicine (Baltimore); 2024 Apr; 103(17):e37923. PubMed ID: 38669361
[TBL] [Abstract][Full Text] [Related]
2. [Primary central nervous system lymphoma--a report of 32 cases with literature review].
Yi JQ; Lin TY; He YJ; Huang HQ; Xia ZJ; Xia YF; Xu RH; Guo Y; Guan ZZ
Ai Zheng; 2006 Apr; 25(4):476-80. PubMed ID: 16613684
[TBL] [Abstract][Full Text] [Related]
3. High-dose chemotherapy with autologous stem cell transplantation following systemic chemotherapy, prophylactic intrathecal methotrexate, and radiotherapy prevents relapse and improves the outcome of advanced stage primary testicular lymphoma even with cardiac involvement.
Lee S; Yamauchi T; Kinoshita K; Imamura S; Kamiya K
J Clin Exp Hematop; 2017 Oct; 57(2):64-68. PubMed ID: 28883219
[TBL] [Abstract][Full Text] [Related]
4. Cerebellar large B-cell lymphoma: a case report.
Ghannam M; Mansour S; Jumah F; Berry B; Beard A
J Med Case Rep; 2018 Nov; 12(1):341. PubMed ID: 30446015
[TBL] [Abstract][Full Text] [Related]
5. Dose-intensified CHOP with rituximab (R-Double-CHOP) followed by consolidation high-dose chemotherapies for patients with advanced diffuse large B-cell lymphoma.
Kurita D; Miura K; Nakagawa M; Ohtake S; Sakagami M; Uchino Y; Takahashi H; Kiso S; Hojo A; Kodaira H; Yagi M; Hirabayashi Y; Kobayashi Y; Iriyama N; Kobayashi S; Hatta Y; Kura Y; Sugitani M; Takei M
Int J Hematol; 2015 Jun; 101(6):585-93. PubMed ID: 25776837
[TBL] [Abstract][Full Text] [Related]
6. Relapsed lymphoma mimicking venous ulcer: A case report.
Kamal WSA; Affandi AM; Bhullar A; Kamal WSZ
Med J Malaysia; 2018 Aug; 73(4):253-254. PubMed ID: 30121690
[TBL] [Abstract][Full Text] [Related]
7. Intrathecal methotrexate prophylaxis and central nervous system relapse in patients with diffuse large B-cell lymphoma following rituximab plus cyclophosphamide, doxorubicin, vincristine and prednisone.
Tomita N; Takasaki H; Ishiyama Y; Kishimoto K; Ishibashi D; Koyama S; Ishii Y; Takahashi H; Numata A; Watanabe R; Tachibana T; Ohshima R; Hagihara M; Hashimoto C; Takemura S; Taguchi J; Fujimaki K; Sakai R; Motomura S; Ishigatsubo Y
Leuk Lymphoma; 2015 Mar; 56(3):725-9. PubMed ID: 24913502
[TBL] [Abstract][Full Text] [Related]
8. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
[TBL] [Abstract][Full Text] [Related]
9. Relapsed diffuse large B-cell lymphoma--10 years later.
Jain S; Shah N; Gregory S
Clin Adv Hematol Oncol; 2011 Sep; 9(9):704-8. PubMed ID: 22402517
[No Abstract] [Full Text] [Related]
10. Combination of ibrutinib with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treatment-naive patients with CD20-positive B-cell non-Hodgkin lymphoma: a non-randomised, phase 1b study.
Younes A; Thieblemont C; Morschhauser F; Flinn I; Friedberg JW; Amorim S; Hivert B; Westin J; Vermeulen J; Bandyopadhyay N; de Vries R; Balasubramanian S; Hellemans P; Smit JW; Fourneau N; Oki Y
Lancet Oncol; 2014 Aug; 15(9):1019-26. PubMed ID: 25042202
[TBL] [Abstract][Full Text] [Related]
11. [Therapeutic management of central nervous system lymphomas in a single hematological institute].
Iványi JL; Marton E; Plander M; Gyánó G; Czumbil L; Tóth C
Orv Hetil; 2009 Oct; 150(42):1937-44. PubMed ID: 19812012
[TBL] [Abstract][Full Text] [Related]
12. Unilateral uveitis masquerade syndrome caused by diffuse large B-cell lymphoma diagnosed using multiparametric flow cytometry of the aqueous humor.
Monsalvo S; Serrano C; Prieto E; Fernández-Sanz G; Puente MC; Rodriguez-Pinilla M; Garcia Raso A; Llamas P; Cordoba R
Cytometry B Clin Cytom; 2017 Jul; 92(4):286-290. PubMed ID: 26860883
[TBL] [Abstract][Full Text] [Related]
13. Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.
Savage KJ; Al-Rajhi N; Voss N; Paltiel C; Klasa R; Gascoyne RD; Connors JM
Ann Oncol; 2006 Jan; 17(1):123-30. PubMed ID: 16236753
[TBL] [Abstract][Full Text] [Related]
14. Primary cutaneous diffuse large B cell lymphoma-other successfully treated by the combination of R-CHOP chemotherapy and surgery: A case report and review of literature.
Jia J; Li W; Zheng Y
Medicine (Baltimore); 2017 Feb; 96(8):e6161. PubMed ID: 28225499
[TBL] [Abstract][Full Text] [Related]
15. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
[TBL] [Abstract][Full Text] [Related]
16. Diffuse large B-cell lymphoma presenting as a sacral tumor. Report of two cases.
Liu JK; Kan P; Schmidt MH
Neurosurg Focus; 2003 Aug; 15(2):E10. PubMed ID: 15350041
[TBL] [Abstract][Full Text] [Related]
17. Primary Central Nervous System Lymphoma in an Immunocompetent Patient Presenting as Multiple Cerebellar Lesions: A Case Report and Review of Literature.
Galarza Fortuna GM; Dvir K; Febres-Aldana C; Schwartz M; Medina AM
J Investig Med High Impact Case Rep; 2019; 7():2324709619893548. PubMed ID: 31818145
[TBL] [Abstract][Full Text] [Related]
18. Primary diffuse large B-cell lymphoma in the maxilla: A case report.
Zou H; Yang H; Zou Y; Lei L; Song L
Medicine (Baltimore); 2018 May; 97(20):e10707. PubMed ID: 29768336
[TBL] [Abstract][Full Text] [Related]
19. Intrathecal MTX for DLBCL: from an inappropriate prophylactic tradition to a medical error?
Dietrich PY
Blood; 2009 Aug; 114(9):1999; author reply 1999. PubMed ID: 19713482
[No Abstract] [Full Text] [Related]
20. A case of primary dural lymphoma: diffuse large B-cell type.
Lee WH; Kim B; Kim MS
Turk Neurosurg; 2014; 24(5):799-803. PubMed ID: 25269058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
